Haleon PLC (HLN)
9.55
+0.07
(+0.74%)
USD |
NYSE |
Nov 21, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Haleon Debt to Equity Ratio: 0.5263 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.5263 |
| March 31, 2024 | |
| December 31, 2023 | 0.5612 |
| September 30, 2023 | |
| June 30, 2023 | 0.5908 |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.6294 |
| September 30, 2022 | |
| June 30, 2022 | 0.3764 |
| March 31, 2022 | |
| December 31, 2021 | 0.0332 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0332
Minimum
Dec 2021
0.6294
Maximum
Dec 2022
0.4529
Average
0.5437
Median
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7219 |
| GSK PLC | 1.146 |
| Smith & Nephew PLC | 0.6669 |
| Adaptimmune Therapeutics PLC | 0.6234 |
| Biodexa Pharmaceuticals PLC | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 42.24B |
| Total Liabilities (Quarterly) | 21.11B |
| Shareholders Equity (Quarterly) | 21.00B |
| Current Ratio | 0.8375 |
| Net Debt Paydown Yield | 5.08% |